Application 220068
- Type
- ANDA
- Sponsor
- CAPLIN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FOSCARNET SODIUM | FOSCARNET SODIUM | SOLUTION;INTRAVENOUS | 6GM/250ML (24MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220068-001 | FOSCARNET SODIUM | FOSCARNET SODIUM | 6GM/250ML (24MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-05-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220068-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A220068-001 | FOSCARNET SODIUM | 6GM/250ML (24MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-05-13 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A220068-001 | FOSCARNET SODIUM | 6GM/250ML (24MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-05-13 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A220068-001 | FOSCARNET SODIUM | 6GM/250ML (24MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-05-13 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220068-001 | FOSCARNET SODIUM | 6GM/250ML (24MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-05-13 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220068-001 | FOSCARNET SODIUM | 6GM/250ML (24MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-05-13 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A220068-001 | AP | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A220068-001 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A220068-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220068-001 | AP | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220068-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Foscarnet Sodium | FOSCARNET SODIUM | Somerset Therapeutics, LLC | 29743168-6dd7-4ee0-bc02-10dbcf2b7896 | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | 220068 ANDA220068 |
| Foscarnet Sodium | FOSCARNET SODIUM | Caplin Steriles Limited | 6ec3bb2a-fb40-4d4a-bc1b-feea80cc1a95 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 220068 ANDA220068 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.